(Total Views: 311)
Posted On: 04/23/2018 6:21:02 PM
Post# of 72433
![Avatar](https://investorshangout.com/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
Brilacidin-ABSSSI will be a Phase 3 clinical trial when the company has the estimated $30 million it will cost to complete such a trial.
So yes, Brilacidin is fairly characterized as a drug awaiting a Phase 3 clinical trial.
So yes, Brilacidin is fairly characterized as a drug awaiting a Phase 3 clinical trial.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)